The Board of Directors of Park Medi World Limited convened a meeting on May 15, 2026, commencing at 04:00 P.M. (IST) and concluding at 04:57 P.M. (IST), wherein it approved the appointment of three auditing firms. The decisions were made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Key Auditor Appointments Approved

The board, acting upon the recommendation of the Audit Committee, approved appointments across three auditing roles. The following table summarises the key details of each appointment:

Cost Auditor: Sachin Gupta & Co.

Sachin Gupta & Co., Cost Accountants, was appointed as the Cost Auditor of Park Medi World Limited for financial year 2026-27. The firm is registered with the Institute of Cost Accountants of India (ICAI) and maintains offices in Noida and Moradabad. It is engaged in the fields of Cost Audit and Compliances, Cost Consultancy, Company Law, Indirect Taxes, and accountancy, covering a wide range of activities related to the profession.

Internal Auditor: NKSC & Co.

NKSC & Co., Chartered Accountants, was appointed as the Internal Auditor for financial year 2026-27. The firm is described as a full-service firm of corporate strategists, auditors, tax advisory experts, and financial analysts, with over 20 years of value-added expertise. The firm's team comprises 40+ domain experts, including Chartered Accountants, Ind AS (IFRS) specialists, Finance specialists, Accounting Professionals, and Company Secretaries.

Secretarial Auditor: SBR & Co. LLP

SBR & Co. LLP, Company Secretaries, was appointed as Secretarial Auditor for a term of five consecutive years from financial year 2025-26 to 2029-30. This appointment is subject to the approval of shareholders at the ensuing Annual General Meeting, in compliance with the amended provisions of Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Section 204 of the Companies Act, 2013. The firm holds a valid Peer Review Certificate, is headquartered in Mumbai, and has a branch in Delhi-NCR with associates representing in all major cities of India. Its partners have wide-ranging experience in handling complex issues on corporate laws.

The disclosures pertaining to all three appointments, including brief profiles and terms of engagement, were filed with BSE Limited and the National Stock Exchange of India Limited as required under the applicable listing regulations. The announcement was signed by Abhishek Kapoor, Company Secretary and Compliance Officer of Park Medi World Limited.

Park Medi World Limited has released the transcript of its earnings conference call held on May 13, 2026, discussing the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transcript is available on the company's investor relations website.

Financial Performance FY26

The company reported its highest-ever annual revenue of INR1,679 crores for the financial year ended March 31, 2026, representing a year-on-year growth of 21%. Profit after tax (PAT) for the year stood at INR274 crores, a 27% increase compared to the previous year. The EBITDA for the year was INR444 crores, up 20% year-on-year, with an EBITDA margin of 26% and a net profit margin of 16%.

Operational Highlights

During FY26, the company added 610 beds, increasing its capacity from 3,000 beds to 3,610 beds as of March 31, 2026. This included a new 250-bed facility in Bathinda and a 360-bed unit in Agra. Network occupancy for Q4 FY26 stood at 62.5%, while full-year occupancy improved by 244 basis points to 64.1%. The company served approximately 8.7 lakh patients during the financial year, the highest in its history.

Q4 FY26 Results

For the fourth quarter, total revenue stood at INR460 crores, a growth of 30% year-on-year. Operating EBITDA for the quarter was INR127 crores, up 44% year-on-year with a margin of 28%. Profit after tax for Q4 was INR77 crores, registering a growth of 47% year-on-year with a PAT margin of 17%.

Balance Sheet and Future Outlook

As of March 31, 2026, the gross term debt was INR28 crores, significantly reduced from INR450 crores in the previous year. The bank balance increased to INR352 crores, including fixed deposits of INR314 crores. The company has 1,500 beds under execution, expected to be operational by March 2028, which will take the total bed capacity to 5,460.